NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

市场调查报告书

肢端肥大症(AC) - 流行病学的预测 ~2027年

Acromegaly - Epidemiology Forecast to 2028

出版商 DelveInsight Business Research LLP 商品编码 524433
出版日期 按订单生产 内容资讯 英文 50 Pages
商品交期: 10个工作天内
价格
肢端肥大症(AC) - 流行病学的预测 ~2027年 Acromegaly - Epidemiology Forecast to 2028
出版日期: 按订单生产内容资讯: 英文 50 Pages
简介

主要7个国家(美国,英国,德国,法国,义大利,西班牙,日本)的肢端肥大症(AC)的总患病数2016年估计为6万610人。

本报告提供肢端肥大症(AC)的相关调查,疾病概要,患者背景,主要7个国家肢端肥大症(AC)的患病数、诊断数、可治疗病例数预测(今后10年份),市场成长机会等资讯。

目录

第1章 重要的洞察

第2章 疾病概要:肢端肥大症(AC)

  • 简介
  • 征兆与症状
  • 下垂体腺瘤的分类
  • 肢端肥大症临床症状
  • 病因
  • 病理生理学
  • 肢端肥大症的遗传性要素
  • 病因
  • 诊断
    • 诊断指南
    • 内分泌学会诊疗指南作成委员(英国)
    • 美国临床内分泌学会(美国)

第3章 流行病学和患者人口

第4章 主要觀察

第5章 主要7个国家的流行病学

  • 主要7个国家肢端肥大症的总患病数
  • 主要7个国家肢端肥大症的患病数:各原因

第6章 美国的流行病学

  • 肢端肥大症(AC)的患病数
  • 肢端肥大症(AC)的患病数:各原因
  • 肢端肥大症(AC)的诊断数
  • 肢端肥大症(AC)的诊断数:各腺瘤
  • 肢端肥大症(AC)的可治疗病例数

第7章 欧洲5个国家的流行病学

  • 英国
    • 肢端肥大症(AC)的患病数
    • 肢端肥大症(AC)的患病数:各原因
    • 肢端肥大症(AC)的诊断数
    • 肢端肥大症(AC)的诊断数:各腺瘤
    • 肢端肥大症(AC)的可治疗病例数病例数
  • 德国
    • 肢端肥大症(AC)的患病数
    • 肢端肥大症(AC)的患病数:各原因
    • 肢端肥大症(AC)的诊断数
    • 肢端肥大症(AC)的诊断数:各腺瘤
    • 肢端肥大症(AC)的可治疗病例数病例数
  • 法国
    • 肢端肥大症(AC)的患病数
    • 肢端肥大症(AC)的患病数:各原因
    • 肢端肥大症(AC)的诊断数
    • 肢端肥大症(AC)的诊断数:各腺瘤
    • 肢端肥大症(AC)的可治疗病例数病例数
  • 义大利
    • 肢端肥大症(AC)的患病数
    • 肢端肥大症(AC)的患病数:各原因
    • 肢端肥大症(AC)的诊断数
    • 肢端肥大症(AC)的诊断数:各腺瘤
    • 肢端肥大症(AC)的可治疗病例数病例数
  • 西班牙
    • 肢端肥大症(AC)的患病数
    • 肢端肥大症(AC)的患病数:各原因
    • 肢端肥大症(AC)的诊断数
    • 肢端肥大症(AC)的诊断数:各腺瘤
    • 肢端肥大症(AC)的可治疗病例数病例数

第8章 日本的流行病学

  • 肢端肥大症(AC)的患病数
  • 肢端肥大症(AC)的患病数:各原因
  • 肢端肥大症(AC)的诊断数
  • 肢端肥大症(AC)的诊断数:各腺瘤
  • 肢端肥大症(AC)的可治疗病例数病例数

第9章 未满足需求

第10章 附录

  • 调查方法

第11章 DelveInsight的服务内容

第12章 免责声明

第13章 关于DelveInsight

目录
Product Code: DIEI0017

DelveInsight's "Acromegaly - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Acromegaly epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

  • United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2016-2028

Acromegaly Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Acromegaly in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Acromegaly outlook. It also includes the explanation of changing trends of epidemiology outlining the Acromegaly scenario.

Acromegaly Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Acromegaly thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

  • The report covers detailed overview of Acromegaly explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
  • The Acromegaly Report assesses the disease risk and burden and highlights the unmet needs
  • It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

  • 10 Year Forecast
  • 7MM Coverage
  • Total Cases in Acromegaly

Key assessments

  • Patient Segmentation in Acromegaly
  • Acromegaly Risk & Burden
  • Factors driving growth in a specific Acromegaly patient population

Table of Contents

1. Report Introduction

2. Acromegaly Epidemiology Overview at a Glance

  • 2.1. Patient Share Distribution of Acromegaly in 2016
  • 2.2. Patient Share Distribution of Acromegaly in 2028

3. Disease Background and Overview: Acromegaly

  • 3.1. Introduction
  • 3.2. Symptoms
  • 3.3. Etiology
  • 3.4. Risk Factors
  • 3.5. Pathophysiology
  • 3.6. Diagnosis
  • 3.7. Treatment

4. Epidemiology and Patient Population

  • 4.1. Key Findings
  • 4.2. Total Prevalent/ Incident Patient Population of Acromegaly in 7MM
  • 4.3. Total Prevalent/ Incident Patient Population of Acromegaly in 7MM - By Countries

5. Epidemiology of Acromegaly by Countries

  • 5.1. United States
    • 5.1.1. Assumptions and Rationale
    • 5.1.2. Prevalent/Incident Cases of the Acromegaly
    • 5.1.3. Sub-Type Specific cases of the Acromegaly *
    • 5.1.4. Sex- Specific Cases of the Acromegaly *
    • 5.1.5. Diagnosed Cases of the Acromegaly
  • 5.2. EU5
  • 5.3. Assumptions and Rationale
  • 5.4. Germany
    • 5.4.1. Assumptions and Rationale
    • 5.4.2. Prevalent/Incident Cases of the Acromegaly
    • 5.4.3. Sub-Type Specific cases of the Acromegaly *
    • 5.4.4. Sex- Specific Cases of the Acromegaly *
    • 5.4.5. Diagnosed Cases of the Acromegaly
  • 5.5. France
    • 5.5.1. Assumptions and Rationale
    • 5.5.2. Prevalent/Incident Cases of the Acromegaly
    • 5.5.3. Sub-Type Specific cases of the Acromegaly *
    • 5.5.4. Sex- Specific Cases of the Acromegaly *
    • 5.5.5. Diagnosed Cases of the Acromegaly
  • 5.6. Italy
    • 5.6.1. Assumptions and Rationale
    • 5.6.2. Prevalent/Incident Cases of the Acromegaly
    • 5.6.3. Sub-Type Specific cases of the Acromegaly *
    • 5.6.4. Sex- Specific Cases of the Acromegaly *
    • 5.6.5. Diagnosed Cases of the Acromegaly
  • 5.7. Spain
    • 5.7.1. Assumptions and Rationale
    • 5.7.2. Prevalent/Incident Cases of the Acromegaly
    • 5.7.3. Sub-Type Specific cases of the Acromegaly *
    • 5.7.4. Sex- Specific Cases of the Acromegaly *
    • 5.7.5. Diagnosed Cases of the Acromegaly
  • 5.8. United Kingdom
    • 5.8.1. Assumptions and Rationale
    • 5.8.2. Prevalent/Incident Cases of the Acromegaly
    • 5.8.3. Sub-Type Specific cases of the Acromegaly *
    • 5.8.4. Sex- Specific Cases of the Acromegaly *
    • 5.8.5. Diagnosed Cases of the Acromegaly
  • 5.9. Japan
    • 5.9.1. Assumptions and Rationale
    • 5.9.2. Prevalent/Incident Cases of the Acromegaly
    • 5.9.3. Sub-Type Specific cases of the Acromegaly *
    • 5.9.4. Sex- Specific Cases of the Acromegaly *
    • 5.9.5. Diagnosed Cases of the Acromegaly

6. Unmet Needs of the Acromegaly

7. Appendix

8. Report Methodology

  • 8.1. Sources

9. DelveInsight Capabilities

10. Disclaimer

11. About DelveInsight

Indication Specific

List of Tables

  • Table 1: Total Prevalent/Incident Cases of the Acromegaly in 7MM
  • Table 2: Total Prevalent/Incident Cases of the Acromegaly in 7MM by Countries
  • Table 3: Prevalent/Incident Cases of the Acromegaly in United States (2016-2028)
  • Table 4: Sub-Type Specific cases of the Acromegaly in United States (2016-2028)*
  • Table 5: Sex- Specific Cases of the Acromegaly in United States (2016-2028)*
  • Table 6: Diagnosed Cases of the Acromegaly in United States (2016-2028)
  • Table 7: Prevalent/Incident Cases of the Acromegaly in Germany (2016-2028)
  • Table 8: Sub-Type Specific cases of the Acromegaly in Germany (2016-2028) *
  • Table 9: Sex- Specific Cases of the Acromegaly in Germany (2016-2028) *
  • Table 10: Diagnosed Cases of the Acromegaly in Germany (2016-2028)
  • Table 11: Prevalent/Incident Cases of the Acromegaly in France (2016-2028)
  • Table 12: Sub-Type Specific cases of the Acromegaly in France (2016-2028) *
  • Table 13: Sex- Specific Cases of the Acromegaly in France (2016-2028) *
  • Table 14: Diagnosed Cases of the Acromegaly in France (2016-2028)
  • Table 15: Prevalent/Incident Cases of the Acromegaly in Italy (2016-2028)
  • Table 16: Sub-Type Specific cases of the Acromegaly in Italy (2016-2028) *
  • Table 17: Sex- Specific Cases of the Acromegaly in Italy (2016-2028) *
  • Table 18: Diagnosed Cases of the Acromegaly in Italy (2016-2028)
  • Table 19: Prevalent/Incident Cases of the Acromegaly in Spain (2016-2028)
  • Table 20: Sub-Type Specific cases of the Acromegaly in Spain (2016-2028) *
  • Table 21: Sex- Specific Cases of the Acromegaly in Spain (2016-2028) *
  • Table 22: Diagnosed Cases of the Acromegaly in Spain (2016-2028)
  • Table 23: Prevalent/Incident Cases of the Acromegaly in UK (2016-2028)
  • Table 24: Sub-Type Specific cases of the Acromegaly in UK (2016-2028) *
  • Table 25: Sex- Specific Cases of the Acromegaly in UK (2016-2028) *
  • Table 26: Diagnosed Cases of the Acromegaly in UK (2016-2028)
  • Table 27: Prevalent/Incident Cases of the Acromegaly in Japan (2016-2028)
  • Table 28: Sub-Type Specific cases of the Acromegaly in Japan (2016-2028) *
  • Table 29: Sex- Specific Cases of the Acromegaly in Japan (2016-2028) *
  • Table 30: Diagnosed Cases of the Acromegaly in Japan (2016-2028)

List of Figures

  • Figure 1: Total Prevalent/Incident Cases of the Acromegaly in 7MM
  • Figure 2: Total Prevalent/Incident Cases of the Acromegaly in 7MM by Countries
  • Figure 3: Prevalent/Incident Cases of the Acromegaly in United States (2016-2028)
  • Figure 4: Sub-Type Specific cases of the Acromegaly in United States (2016-2028)*
  • Figure 5: Sex- Specific Cases of the Acromegaly in United States (2016-2028)*
  • Figure 6: Diagnosed Cases of the Acromegaly in United States (2016-2028)
  • Figure 7: Prevalent/Incident Cases of the Acromegaly in Germany (2016-2028)
  • Figure 8: Sub-Type Specific cases of the Acromegaly in Germany (2016-2028) *
  • Figure 9: Sex- Specific Cases of the Acromegaly in Germany (2016-2028) *
  • Figure 10: Diagnosed Cases of the Acromegaly in Germany (2016-2028)
  • Figure 11: Prevalent/Incident Cases of the Acromegaly in France (2016-2028)
  • Figure 12: Sub-Type Specific cases of the Acromegaly in France (2016-2028) *
  • Figure 13: Sex- Specific Cases of the Acromegaly in France (2016-2028) *
  • Figure 14: Diagnosed Cases of the Acromegaly in France (2016-2028)
  • Figure 15: Prevalent/Incident Cases of the Acromegaly in Italy (2016-2028)
  • Figure 16: Sub-Type Specific cases of the Acromegaly in Italy (2016-2028) *
  • Figure 17: Sex- Specific Cases of the Acromegaly in Italy (2016-2028) *
  • Figure 18: Diagnosed Cases of the Acromegaly in Italy (2016-2028)
  • Figure 19: Prevalent/Incident Cases of the Acromegaly in Spain (2016-2028)
  • Figure 20: Sub-Type Specific cases of the Acromegaly in Spain (2016-2028) *
  • Figure 21: Sex- Specific Cases of the Acromegaly in Spain (2016-2028) *
  • Figure 22: Diagnosed Cases of the Acromegaly in Spain (2016-2028)
  • Figure 23: Prevalent/Incident Cases of the Acromegaly in UK (2016-2028)
  • Figure 24: Sub-Type Specific cases of the Acromegaly in UK (2016-2028) *
  • Figure 25: Sex- Specific Cases of the Acromegaly in UK (2016-2028) *
  • Figure 26: Diagnosed Cases of the Acromegaly in UK (2016-2028)
  • Figure 27: Prevalent/Incident Cases of the Acromegaly in Japan (2016-2028)
  • Figure 28: Sub-Type Specific cases of the Acromegaly in Japan (2016-2028) *
  • Figure 29: Sex- Specific Cases of the Acromegaly in Japan (2016-2028) *
  • Figure 30: Diagnosed Cases of the Acromegaly in Japan (2016-2028)